Teachers Advisors’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$9.02M Buy
398,695
+7,889
+2% +$174K 0.01% 1047
2018
Q4
$8.84M Buy
390,806
+3,247
+0.8% +$80.8K 0.01% 988
2018
Q3
$11.1M Sell
387,559
-939
-0.2% -$26.8K 0.01% 1034
2018
Q2
$10.6M Buy
388,498
+39,016
+11% +$1.04M 0.01% 1060
2018
Q1
$7.81M Sell
349,482
-24,121
-6% -$574K 0.01% 1123
2017
Q4
$7.87M Sell
373,603
-200
-0.1% -$4.57K 0.01% 1143
2017
Q3
$9.3M Buy
373,803
+3,554
+1% +$78.3K 0.01% 1057
2017
Q2
$7.18M Buy
370,249
+2,975
+0.8% +$54K 0.01% 1152
2017
Q1
$6.78M Buy
367,274
+74,186
+25% +$1.45M 0.01% 1152
2016
Q4
$5.55M Buy
293,088
+16,214
+6% +$332K 0.01% 1230
2016
Q3
$6.2M Buy
276,874
+42,430
+18% +$808K 0.01% 1126
2016
Q2
$4.17M Buy
234,444
+2,952
+1% +$47.8K 0.01% 1252
2016
Q1
$3.16M Buy
231,492
+28,956
+14% +$439K 0.01% 1344
2015
Q4
$3.91M Buy
202,536
+30,400
+18% +$607K 0.01% 1230
2015
Q3
$3.49M Buy
172,136
+745
+0.4% +$22.1K 0.01% 1263
2015
Q2
$5.68M Buy
171,391
+134,748
+368% +$3.69M 0.01% 1122
2015
Q1
$878K Buy
36,643
+8,025
+28% +$122K ﹤0.01% 2118
2014
Q4
$350K Hold
28,618
﹤0.01% 2639
2014
Q3
$258K Hold
28,618
﹤0.01% 2753
2014
Q2
$336K Buy
28,618
+1,168
+4% +$15.8K ﹤0.01% 2675
2014
Q1
$584K Buy
+27,450
New +$422K ﹤0.01% 2315

Other funds holding TVTX

Teachers Advisors's TVTX Position: Q1 2019 in Review

Teachers Advisors increased its Travere Therapeutics (TVTX) stake by 2% in Q1 2019, buying an estimated $174K and bringing the position to 398,695 shares worth $9.02M. The position accounts for 0.01% of the portfolio, ranked #1047.

Teachers Advisors first reported a position in TVTX in Q1 2014 and has held it in 21 quarters since. The position peaked at $11.1M in Q3 2018. 131 funds tracked by Wall St. Rank hold TVTX as of Q1 2019.

  • Teachers Advisors held 398,695 shares of Travere Therapeutics worth $9.02M as of Q1 2019.
  • Teachers Advisors bought 7,889 Travere Therapeutics shares in Q1 2019, an estimated $174K.
  • Travere Therapeutics made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1047 holding.
  • Teachers Advisors first reported a position in Travere Therapeutics in Q1 2014 and has held it in 21 quarters since.
  • Teachers Advisors's Travere Therapeutics position peaked at $11.1M in Q3 2018.
  • 131 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.